|
1
|
Kumar R Shalimar, Sharma H, Goyal R, Kumar
A, Khanal S, Prakash S, Gupta SD, Panda SK and Acharya SK:
Prospective derivation and validation of early dynamic model for
predicting outcome in patients with acute liver failure. Gut.
61:1068–1075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gowda S, Desai PB, Hull VV, Math AA,
Vernekar SN and Kulkarni SS: A review on laboratory liver function
tests. Pan Afr Med J. 3:172009.PubMed/NCBI
|
|
3
|
Nie W, Yan L, Lee YH, Guha C, Kurland IJ
and Lu H: Advanced mass spectrometry-based multi-omics technologies
for exploring the pathogenesis of hepatocellular carcinoma. Mass
Spectrom Rev. 35:331–349. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chaiteerakij R, Addissie BD and Roberts
LR: Update on biomarkers of hepatocellular carcinoma. Clin
Gastroenterol Hepatol. 13:237–245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smolinska A, Blanchet L, Buydens LM and
Wijmenga SS: NMR and pattern recognition methods in metabolomics:
from data acquisition to biomarker discovery: a review. Anal Chim
Acta. 750:82–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang Y, Li C, Nie X, Feng X, Chen W, Yue
Y, Tang H and Deng F: Metabonomic studies of human hepatocellular
carcinoma using high-resolution magic-angle spinning 1H NMR
spectroscopy in conjunction with multivariate data analysis. J
Proteome Res. 6:2605–2614. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tripathi P, Bala L, Saxena R, Yachha SK,
Roy R and Khetrapal CL: 1H NMR spectroscopic study of blood serum
for the assessment of liver function in liver transplant patients.
J Gastrointestin Liver Dis. 18:329–336. 2009.PubMed/NCBI
|
|
8
|
Qi S, Tu Z, Ouyang X, Wang L, Peng W, Cai
A and Dai Y: Comparison of the metabolic profiling of hepatitis B
virus-infected cirrhosis and alcoholic cirrhosis patients by using
(1) H NMR-based metabonomics. Hepatol Res. 42:677–685. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng S, Wiklund P, Autio R, Borra R,
Ojanen X, Xu L, Törmäkangas T and Alen M: Adipose Tissue
Dysfunction and Altered Systemic Amino Acid Metabolism Are
Associated with Non-Alcoholic Fatty Liver Disease. PLoS One.
10:e01388892015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi SW, Tu ZG, Peng WJ, Wang LX, Ou-Yang X,
Cai AJ and Dai Y: 1H NMR-based serum metabolic profiling in
compensated and decompensated cirrhosis. World J Gastroenterol.
18:285–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Winnike JH, Li Z, Wright FA, Macdonald JM,
O'Connell TM and Watkins PB: Use of pharmaco-metabonomics for early
prediction of acetaminophen-induced hepatotoxicity in humans. Clin
Pharmacol Ther. 88:45–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cobbold JF, Patel JH, Goldin RD, North BV,
Crossey MM, Fitzpatrick J, Wylezinska M, Thomas HC, Cox IJ and
Taylor-Robinson SD: Hepatic lipid profiling in chronic hepatitis C:
An in vitroin vivo proton magnetic resonance spectroscopy study. J
Hepatol. 52:16–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amathieu R, Nahon P, Triba M, Bouchemal N,
Trinchet JC, Beaugrand M, Dhonneur G and Le Moyec L: Metabolomic
approach by 1H NMR spectroscopy of serum for the assessment of
chronic liver failure in patients with cirrhosis. J Proteome Res.
10:3239–3245. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martínez-Granados B, Morales JM, Rodrigo
JM, Del Olmo J, Serra MA, Ferrández A, Celda B and Monleón D:
Metabolic profile of chronic liver disease by NMR spectroscopy of
human biopsies. Int J Mol Med. 27:111–117. 2011.PubMed/NCBI
|
|
15
|
Embade N, Mariño Z, Diercks T, Cano A,
Lens S, Cabrera D, Navasa M, Falcón-Pérez JM, Caballería J, Castro
A, et al: Metabolic Characterization of Advanced Liver Fibrosis in
HCV Patients as Studied by Serum 1H-NMR Spectroscopy. PLoS One.
11:e01550942016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nahon P, Amathieu R, Triba MN, Bouchemal
N, Nault JC, Ziol M, Seror O, Dhonneur G, Trinchet JC, Beaugrand M,
et al: Identification of serum proton NMR metabolomic fingerprints
associated with hepatocellular carcinoma in patients with alcoholic
cirrhosis. Clin Cancer Res. 18:6714–6722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saxena V, Gupta A, Gowda GA Nagana, Saxena
R, Yachha SK and Khetrapal CL: 1H NMR spectroscopy for the
prediction of therapeutic outcome in patients with fulminant
hepatic failure. NMR Biomed. 19:521–526. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Munshi SU, Taneja S, Bhavesh NS, Shastri
J, Aggarwal R and Jameel S: Metabonomic analysis of hepatitis E
patients shows deregulated metabolic cycles and abnormalities in
amino acid metabolism. J Viral Hepat. 18:e591–e602. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Serkova NJ, Zhang Y, Coatney JL, Hunter L,
Wachs ME, Niemann CU and Mandell MS: Early detection of graft
failure using the blood metabolic profile of a liver recipient.
Transplantation. 83:517–521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Andersson U, Lindberg J, Wang S,
Balasubramanian R, Marcusson-Ståhl M, Hannula M, Zeng C, Juhasz PJ,
Kolmert J, Bäckström J, et al: A systems biology approach to
understanding elevated serum alanine transaminase levels in a
clinical trial with ximelagatran. Biomarkers. 14:572–586. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiménez B, Montoliu C, MacIntyre DA, Serra
MA, Wassel A, Jover M, Romero-Gomez M, Rodrigo JM, Pineda-Lucena A
and Felipo V: Serum metabolic signature of minimal hepatic
encephalopathy by (1)H-nuclear magnetic resonance. J Proteome Res.
9:5180–5187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shariff MI, Gomaa AI, Cox IJ, Patel M,
Williams HR, Crossey MM, Thillainayagam AV, Thomas HC, Waked I,
Khan SA, et al: Urinary metabolic biomarkers of hepatocellular
carcinoma in an Egyptian population: A validation study. J Proteome
Res. 10:1828–1836. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McPhail MJ, Shawcross DL, Lewis MR,
Coltart I, Want EJ, Antoniades CG, Veselkov K, Triantafyllou E,
Patel V, Pop O, et al: Multivariate metabotyping of plasma predicts
survival in patients with decompensated cirrhosis. J Hepatol.
64:1058–1067. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ranjan P, Gupta A, Kumar S, Gowda GA,
Ranjan A, Sonker AA, Chandra A and Ramakant: Detection of new amino
acid markers of liver trauma by proton nuclear magnetic resonance
spectroscopy. Liver Int. 26:703–707. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharif AW, Williams HR, Lampejo T, Khan
SA, Bansi DS, Westaby D, Thillainayagam AV, Thomas HC, Cox IJ and
Taylor-Robinson SD: Metabolic profiling of bile in
cholangiocarcinoma using in vitro magnetic resonance spectroscopy.
HPB Oxf. 12:396–402. 2010. View Article : Google Scholar
|
|
26
|
Shariff MI, Ladep NG, Cox IJ, Williams HR,
Okeke E, Malu A, Thillainayagam AV, Crossey MM, Khan SA, Thomas HC,
et al: Characterization of urinary biomarkers of hepatocellular
carcinoma using magnetic resonance spectroscopy in a Nigerian
population. J Proteome Res. 9:1096–1103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goossens C, Nahon P, Le Moyec L, Triba MN,
Bouchemal N, Amathieu R, Ganne-Carrié N, Ziol M, Trinchet JC,
Sellier N, et al: Sequential Serum Metabolomic Profiling after
Radiofrequency Ablation of Hepatocellular Carcinoma Reveals
Different Response Patterns According to Etiology. J Proteome Res.
15:1446–1454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duarte IF, Stanley EG, Holmes E, Lindon
JC, Gil AM, Tang H, Ferdinand R, McKee CG, Nicholson JK,
Vilca-Melendez H, et al: Metabolic assessment of human liver
transplants from biopsy samples at the donor and recipient stages
using high-resolution magic angle spinning 1H NMR spectroscopy.
Anal Chem. 77:5570–5578. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jackson JE: A User's Guide To Principal
Components. John Wiley & Sons, Inc.; Hoboken, NJ: 1991,
View Article : Google Scholar
|
|
30
|
Holmes E, Foxall PJ, Nicholson JK, Neild
GH, Brown SM, Beddell CR, Sweatman BC, Rahr E, Lindon JC, Spraul M,
et al: Automatic data reduction and pattern recognition methods for
analysis of 1H nuclear magnetic resonance spectra of human urine
from normal and pathological states. Anal Biochem. 220:284–296.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wold S, Sjöström M and Eriksson L:
PLS-regression: A basic tool of chemometrics. Chemom Intell Lab
Syst. 58:109–130. 2001. View Article : Google Scholar
|
|
32
|
Barker M and Rayens W: Partial least
squares for discrimination. J Chemometr. 17:166–173. 2003.
View Article : Google Scholar
|
|
33
|
Trygg J and Wold S: Orthogonal projections
to latent structures (O-PLS). J Chemometr. 16:119–128. 2002.
View Article : Google Scholar
|
|
34
|
Triba MN, Le Moyec L, Amathieu R, Goossens
C, Bouchemal N, Nahon P, Rutledge DN and Savarin P: PLS/OPLS models
in metabolomics: The impact of permutation of dataset rows on the
K-fold cross-validation quality parameters. Mol Biosyst. 11:13–19.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Godoy MM, Lopes EP, Silva RO, Hallwass F,
Koury LC, Moura IM, Gonçalves SM and Simas AM: Hepatitis C virus
infection diagnosis using metabonomics. J Viral Hepat. 17:854–858.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Westerhuis JA, van Velzen EJ, Hoefsloot HC
and Smilde AK: Multivariate paired data analysis: Multilevel PLSDA
versus OPLSDA. Metabolomics. 6:119–128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Hong Z, Tan G, Dong X, Yang G, Zhao
L, Chen X, Zhu Z, Lou Z, Qian B, et al: NMR and LC/MS-based global
metabolomics to identify serum biomarkers differentiating
hepatocellular carcinoma from liver cirrhosis. Int J Cancer.
135:658–668. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fonville JM, Bylesjö M, Coen M, Nicholson
JK, Holmes E, Lindon JC and Rantalainen M: Non-linear modeling of
1H NMR metabonomic data using kernel-based orthogonal projections
to latent structures optimized by simulated annealing. Anal Chim
Acta. 705:72–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kimhofer T, Fye H, Taylor-Robinson S,
Thursz M and Holmes E: Proteomic and metabonomic biomarkers for
hepatocellular carcinoma: A comprehensive review. Br J Cancer.
112:1141–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Amathieu R, Triba MN, Goossens C,
Bouchemal N, Nahon P, Savarin P and Le Moyec L: Nuclear magnetic
resonance based metabolomics and liver diseases: Recent advances
and future clinical applications. World J Gastroenterol.
22:417–426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Toyoda H, Kumada T, Tada T, Niinomi T, Ito
T, Kaneoka Y and Maeda A: Prognostic significance of a combination
of pre- and post-treatment tumor markers for hepatocellular
carcinoma curatively treated with hepatectomy. J Hepatol.
57:1251–1257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang X, Zhang A and Sun H: Power of
metabolomics in diagnosis and biomarker discovery of hepatocellular
carcinoma. Hepatology. 57:2072–2077. 2013. View Article : Google Scholar : PubMed/NCBI
|
